1981-2016年加拿大婴儿百日咳住院趋势:无细胞疫苗时代前后对比
该研究基于加拿大出院摘要数据库,分析1981-2016年小于1岁婴儿百日咳住院情况,比较无细胞疫苗项目实施前(1981-1995)与实施后(2006-2016)的变化。结果显示年均住院率从165.1/10万降至33.6/10万,风险比降低4.9倍,但实施后小于1月龄婴儿住院率仍最高(126.6/10万)。
要点
- 无细胞百日咳疫苗项目实施后,婴儿百日咳年均住院率从165.1/10万降至33.6/10万。
- 实施前ICU入住风险是实施后的1.58倍。
- 实施后小于1月龄婴儿年均住院率最高,达126.6/10万。
核心结论
- 婴儿百日咳住院率随时间大幅下降。
- 小于2月龄婴儿仍是住院和入住ICU的最高风险年龄组。
研究设计与样本
- 基于加拿大出院摘要数据库(DAD)的回顾性分析,纳入1981-2016年出院、年龄小于1岁的百日咳主要诊断住院病例。
- 比较项目实施前(1981-1995)与实施后(2006-2016)两个时期,计算发病率、风险比和率差,并用卡方检验和t检验比较,准泊松分析调查趋势。
主要发现
- 年均住院率从实施前的165.1(95%CI 161.3, 168.9)/10万降至实施后的33.6(95%CI 31.6, 35.6)/10万,风险比降低4.9(95%CI 4.6, 5.2)。
- 实施前ICU入住风险是实施后的1.58倍。
- 实施前2月龄婴儿年均住院率降低幅度最大,为263.3/10万。
- 实施后小于1月龄婴儿年均住院率最高,为126.6(95%CI 113.1, 140.1)/10万。
临床怎么用
- 应关注小于2月龄婴儿的百日咳住院和ICU入住风险,该年龄组仍是最高危人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The acellular pertussis vaccine was introduced into the routine childhood immunization schedule across Canada in 1997-98 and adolescent booster doses were added between 1999 and 2005. We sought to assess the impact of these changes on infant pertussis hospitalizations and admissions to intensive care units (ICU) in Canada. METHODS: Hospitalizations with a primary diagnosis of pertussis were extracted from the Canadian Discharge Abstract Database (DAD) for cases with hospital discharge dates between 1981 and 2016 using relevant ICD-9 and ICD-10 codes. Only cases with age less than one year at time of admission were included. Disease severity was assessed by admission to ICU. Cases were categorized into two periods: pre-program implementation period (1981-1995) and the post-program implementation period (2006-2016). Incidence rates, risk ratios, and rate differences were calculated for each period and comparisons for the two periods were done using chi-squared and t-tests. Quasi Poisson analysis was used to investigate trends. RESULTS: When comparing the pre- and post-implementation periods, the average annual hospitalization rates for infants less than 1 year declined from 165.1 (95% CI 161.3, 168.9) to 33.6 (95% CI 31.6, 35.6) pertussis-related admissions per 100,000 population, with a corresponding reduction in the risk ratio of 4.9 (95% CI 4.6, 5.2). The risk of admission into an ICU was 1.58 times higher in the pre- versus post-implementation period while the highest reduction in average annual hospitalizations was 263.3 admissions per 100,000 population in infants 2 months of age. In the post-implementation period, infants less than 1 month of age had the highest average annual hospitalization rate at 126.6 (95% CI 113.1, 140.1) hospitalizations per 100,000 infants. CONCLUSION: Infant pertussis hospitalizations have reduced greatly over time. Infants under 2 months of age remain the most at-risk age group for hospitalization and admission to ICU.
引用
- Desai S, Schanzer DL, Silva A, et al. Trends in Canadian infant pertussis hospitalizations in the pre- and post-acellular vaccine era, 1981-2016. Vaccine. 2018. PMID: 30392765. doi:10.1016/j.vaccine.2018.10.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。